A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: A study by the Scottish Gynaecological Cancer Trials Group (SGCTG)-Reference-Cited by-同舟云学术

A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: A study by the Scottish Gynaecological Cancer Trials Group (SGCTG)

Published:2006-01 Issue:2 Volume:42 Page:179-185
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Reed N.S.,Poole C.J.,Coleman R.,Parkin D.,Graham J.D.,Kaye S.B.,Ostrowski J.,Duncan I.,Paul J.,Hay A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. What are the current surgical objectives, strategies and technical capabilities of gynecologists treating advanced epithelial ovarian cancer?;Eisenkop;Gynecol Oncol,2001

2. Guidelines for surgical staging of ovarian cancer;Trimbos;Obst Gynecol Surv,1994

3. A prospective randomised clinical trial of melphalan and cisplatinum versus hexamethylmelamine, adriamycin and cyclophosphamide in advanced ovarian cancer;Edwards;Gynecol Oncol,1983

4. Treosulfan in the management of ovarian carcinoma;Fennelly;Obst Gynecol,1977

5. Treosulfan in the treatment of ovarian cancer;Lundvall;Acta Obstet Gynecol Scand,1972

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group;Journal of Gynecologic Oncology;2021

2. Measuring Quality of Life in Ovarian Cancer Clinical Trials—Can We Improve Objectivity and Cross Trial Comparisons?;Cancers;2020-11-07

3. Treosulfan in combination with fludarabine as part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation;Drugs of Today;2020

4. A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve;The Oncologist;2017-12-04

5. A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO);Journal of Cancer Research and Clinical Oncology;2016-11-28